Cargando…

Fibroblast growth factor 21 as a candidate of a novel serum biomarker for mitochondrial diabetes

Serum fibroblast growth factor 21 levels in patients with mitochondrial diabetes might be much higher than in those with other diabetes types. The results of this study could lead to the establishment of a simple method for screening mitochondrial diabetes using peripheral blood serum.[Image: see te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komorita, Yuji, Shiroozu, Akiyo, Nakamura, Hidetoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360381/ https://www.ncbi.nlm.nih.gov/pubmed/37246726 http://dx.doi.org/10.1111/jdi.14030

Ejemplares similares

Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism
por: Finsterer, Josef, et al.
Publicado: (2017)

Onset of type 1 diabetes during bone growth period is associated with increased prevalence of bone fracture: A post‐hoc analysis of a cross‐sectional study
por: Komorita, Yuji, et al.
Publicado: (2022)

Improvement of fibroblast growth factor 21 resistance probably confers the beneficial effects of acute exercise
por: Miao, Li‐Ying, et al.
Publicado: (2016)

Serum Fibroblast Growth Factor 21 Levels Are Correlated with the Severity of Diabetic Retinopathy
por: Lin, Yuan, et al.
Publicado: (2014)

The relationship between serum levels of fibroblast growth factor 21 and diabetic retinopathy
por: Mousavi, Zohre, et al.
Publicado: (2017)

The relationship between serum adipokine fibroblast growth factor‐21 and gestational diabetes mellitus
por: Jia, Xiaojiao, et al.
Publicado: (2022)

Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels
por: Cuevas-Ramos, Daniel, et al.
Publicado: (2012)

Serum Fibroblast Growth Factor 21 in Patients with and without Pterygia
por: Yaghoobi, Gholamhosein, et al.
Publicado: (2020)

Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia)
por: Salehi, Mohammad Hossein, et al.
Publicado: (2013)

In search of acute surgical stress biomarkers: Is ghrelin a potential candidate?
por: Kontoravdis, Nikolaos, et al.
Publicado: (2013)

Elevated serum fibroblast growth factor 21 levels correlate with immune recovery but not mitochondrial dysfunction in HIV infection
por: Payne, Brendan AI, et al.
Publicado: (2013)

Soluble Klotho protein as a novel serum biomarker in patients with acromegaly
por: Dąbrowska, Anna M., et al.
Publicado: (2014)

Serum tsRNA as a novel molecular diagnostic biomarker for lupus nephritis
por: Zhang, Xiaoshan, et al.
Publicado: (2022)

Diabetes due to Mitochondrial Adipopathy
por: Ninomiya, Hiroyo, et al.
Publicado: (2017)

Diabetes due to Mitochondrial Adipopathy
por: Finsterer, Josef, et al.
Publicado: (2017)

Circulating Diabetic Candidate Neurotrophic Factors, Brain-Derived Neurotrophic Factor and Fibroblast Growth Factor 21, in Sleeve Gastrectomy
por: Yen, Hung-Hsuan, et al.
Publicado: (2020)

UQCRFS1N assembles mitochondrial respiratory complex-III into an asymmetric 21-subunit dimer
por: Zong, Shuai, et al.
Publicado: (2018)

Serum ferritin as a biomarker of polycythemia vera?
por: Langabeer, Stephen E.
Publicado: (2018)

Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis
por: Shenoy, Vivek K., et al.
Publicado: (2016)

Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
por: Xiao, Yang, et al.
Publicado: (2015)

Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
por: Knott, ME, et al.
Publicado: (2016)

Serum lipids and diabetic retinopathy
por: Mohan, V.
Publicado: (2013)

Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus
por: Taniguchi, Hirokazu, et al.
Publicado: (2022)

Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
por: Kharitonenkov, Alexei, et al.
Publicado: (2013)

Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme
por: Tan, Sze Kiat, et al.
Publicado: (2018)

Commentary: Evaluating potential glioma serum biomarkers, with future applications
por: Goutnik, Michael, et al.
Publicado: (2022)

“Switched” metabolic acidosis in mitochondrial diabetes mellitus
por: Keidai, Yamato, et al.
Publicado: (2019)

Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes
por: Kim, Won Jin, et al.
Publicado: (2015)

Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes
por: Gao, Ruo-Yao, et al.
Publicado: (2019)

Incidence of severe hypoglycemia and its association with serum adiponectin in Japanese patients with type 1 and insulin‐treated type 2 diabetes: The Fukuoka Diabetes Registry
por: Iwase, Masanori, et al.
Publicado: (2020)

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
por: Maeda, Takahiro, et al.
Publicado: (2019)

Is human platelet lysate (hPL) the ideal candidate to substitute the foetal bovine serum for cell-therapy translational research?
por: Guiotto, M., et al.
Publicado: (2021)

Serum semaphorin4C as an auxiliary diagnostic biomarker for breast cancer
por: Wang, Ya, et al.
Publicado: (2021)

Fibroblast Growth Factor 23 Is a Valuable Predictor of Autosomal Dominant Polycystic Kidney Disease Progression
por: Xue, Cheng, et al.
Publicado: (2021)

Two-stage skin grafting using a basic fibroblast growth factor-impregnated artificial dermis
por: Sugimoto, Ryushiro, et al.
Publicado: (2022)

Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts to promote tumour angiogenesis and growth
por: Yan, Dongdong, et al.
Publicado: (2022)

Anti-mitochondrial antibody–mediated myopathy with cardiac involvement: reply
por: Nagatomo, Yuji, et al.
Publicado: (2023)

Perturbations of Fibroblast Growth Factors 19 and 21 in Type 2 Diabetes
por: Roesch, Stephen L., et al.
Publicado: (2015)

Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
por: Zhang, Xiaoyan, et al.
Publicado: (2015)

Serum Levels of Fibroblast Growth Factor 21 Are Positively Associated with Aortic Stiffness in Patients with Type 2 Diabetes Mellitus
por: Huang, Sin-Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e01n9b3dkpbjp2uos5efg3vda1